• June 3-6, 2024
  • San Diego Convention Center, California


Gillian Fenton

Gillian Fenton, Esq., CLP

Vaccines Legal Operations
Gillian M. Fenton, Esq., CLP has been a member of the Licensing Executives Society (LES, USA & Canada) since 1992, and served as the society President in 2020-2021. Gillian’s contributions to LES and to the field of licensing were recognized with the society’s Frank Barnes Award in October, 2022. She is presently a member of the LES Public Policy Committee and is a volunteer instructor in LES educational courses. Gillian is presently Special Counsel for Innovation and Government Collaborations at GSK. Her practice includes a wide variety of business development transactions, R&D collaborations and nondilutive funding agreements with U.S. Government entities (NIH/NIAID, BARDA, CARB-X and DARPA), all in support of GSK’s vaccines pipeline and platform technologies. Prior to joining GSK, Gillian was VP, Associate General Counsel & Chief Intellectual Property Counsel at Emergent BioSolutions Inc., where she founded the IP department and supported all IP aspects of the company’s IPO and subsequent 9 years of growth through M&A in the vaccines, biodefense, and global health fields. Gillian also spent over ten years in private practice at law firms in Boston, MA and Washington, DC.
Speaking In

white squarewhite


Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.